Nursing interventions to reduce medication errors in paediatrics and neonates: Systematic review and meta-analysis

Takawira C Marufu1, Rachel Bower1, Elizabeth Hendron2

  • 1Nottingham Childrens Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.

Journal of Pediatric Nursing
|September 11, 2021
PubMed

Insights

Implementing targeted nursing interventions significantly reduces pediatric medication administration errors by 64%. Education programs and a bundle approach are key to improving medication safety for children.

Area of Science:

  • Pediatric Nursing
  • Patient Safety
  • Healthcare Quality Improvement

Background:

  • Medication errors pose significant risks and costs to healthcare organizations.
  • Children are disproportionately affected by medication errors, with administration error rates exceeding 70%.

Purpose of the Study:

  • To identify nursing interventions aimed at reducing medication administration errors in pediatric populations.
  • To conduct a meta-analysis evaluating the effectiveness of these interventions.

Main Methods:

  • A systematic review of online databases (BNI, Cochrane, CINAHL, EMBASE, MEDLINE) was performed for studies published between 2000 and 2020.
  • Studies focusing on interventions to reduce medication administration errors in neonates, children, and pediatrics were included.
  • A meta-analysis was conducted on the eligible studies.

Main Results:

  • Eighteen studies met the inclusion criteria, identifying seven key interventions.
  • Educational programs were the most frequently identified intervention (13/18 studies).
  • Meta-analysis revealed a 64% reduction in medication administration errors post-intervention (pooled OR 0.36, P=0.0003).

Conclusions:

  • Medication safety education is a critical component of interventions to decrease administration errors.
  • A multifaceted, bundled approach is necessary to address the complexities of medication errors in pediatric care.
  • Identifying the root causes of errors is essential before implementing targeted interventions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
39
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
44
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
34
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
49
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
40
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K